Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CYP3A5 genotype-guided tacrolimus dosing after living-donor kidney transplantation
NL-OMON22836Not yet recruiting
- Sponsor
- Erasmus MC
- Start
- Apr 2010
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label trial of tacrolimus in kidney transplant, sponsored by Erasmus MC. Primary endpoint: Proportion of patients reaching tacrolimus target trough concentrations on day 3 and day 7. Planned start Apr 2010; status: not yet recruiting.
02
Drugs
tacrolimus
03
Conditions
kidney transplant
Beyond the preview
Go deeper on NL-OMON22836.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON22836.